Other

UK probes mega AstraZeneca deal for US biotech firm

Britain's competition watchdog on Tuesday said it was investigating the planned purchase of US biotech company Alexion by COVID vaccine-maker AstraZeneca in a deal worth $39 billion.

Health

Studies take early look at health law's premiums

Coverage under President Barack Obama's health care law won't be cheap, but two independent private studies show that cost-conscious consumers hunting for lower premiums will have plenty of options.

Other

Pfizer 3Q profit falls 14 pct on generic Lipitor (Update)

(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.

Cardiology

State deregulation of open-heart surgery beneficial to patients

(Medical Xpress)—Certificate of Need, a form of state government regulation designed to keep mortality rates and health care costs down, appears to do neither for heart bypass surgery, according to a health economics researcher ...

page 1 from 2